University of California, Davis (UCD) Release: Tumor Response May Not Be Best Measure Of Efficacy In Non-Small Cell Lung Cancer Treatment

Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness.